Lockheed Martin Corporation LMT
- Market cap
- $120.7B
- P/E
- 19.1×
Follow LMT
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 200.47 | 248.00 | 241.18 | 256.79 | 266.11 | 319.81 | 353.03 | 393.77 | 413.92 | 410.11 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 269.90 | 323.94 | 363.00 | 399.96 | 442.53 | 396.99 | 498.95 | 508.10 | 618.95 | 516.00 |
High Price
|
|||
| 97,000 | 100,000 | 105,000 | 110,000 | 114,000 | 114,000 | 116,000 | 122,000 | 121,000 | 123,000 |
Employees
|
|||
| 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 47,290 | 49,960 | 53,762 | 59,812 | 65,398 | 67,044 | 65,984 | 67,571 | 71,043 | 75,048 |
Revenue
|
|||
| 11.42% | 12.75% | 13.53% | 13.99% | 13.23% | 13.52% | 12.56% | 12.55% | 9.75% | 10.15% |
Gross Margin
|
|||
| 4,754 | 5,246 | 5,838 | 7,241 | 8,235 | 7,550 | 6,680 | 8,098 | 6,220 | 5,922 |
EBT
|
|||
| 10.05% | 10.50% | 10.86% | 12.11% | 12.59% | 11.26% | 10.12% | 11.98% | 8.76% | 7.89% |
EBT Margin
|
|||
| 5,173 | 1,963 | 5,046 | 6,230 | 6,833 | 6,315 | 5,732 | 6,920 | 5,336 | 5,017 |
Net Income
|
|||
| 1,215 | 1,195 | 1,161 | 1,189 | 1,290 | 1,364 | 1,404 | 1,430 | 1,559 | 1,687 |
Depreciation
|
|||
| 158.00 | 173.59 | 188.97 | 212.10 | 233.56 | 242.56 | 250.22 | 269.96 | 298.12 | 322.51 |
Revenue/Sh
|
|||
| 17.71 | 6.96 | 17.74 | 22.09 | 24.40 | 22.85 | 21.74 | 27.65 | 22.39 | 21.56 |
Earnings/Sh
|
|||
| 17.34 | 22.50 | 11.03 | 25.93 | 29.23 | 33.36 | 29.59 | 31.64 | 29.26 | 36.77 |
Cash Flow/Sh
|
|||
| (3.55) | (4.09) | (4.49) | (5.26) | (6.31) | (5.51) | (6.33) | (6.76) | (7.07) | (7.09) |
Capex/Sh
|
|||
| 13.79 | 18.41 | 6.54 | 20.66 | 22.92 | 27.85 | 23.25 | 24.89 | 22.19 | 29.69 |
Free CF/Sh
|
|||
| 5.37 | (2.70) | 5.09 | 11.24 | 21.56 | 39.65 | 35.14 | 27.31 | 26.58 | 28.88 |
Book Value/Sh
|
|||
| 299 | 288 | 285 | 282 | 280 | 276 | 264 | 250 | 238 | 233 |
Shares
|
|||
| 14.57 | 46.03 | 14.76 | 17.64 | 14.55 | 15.56 | 21.92 | 16.50 | 21.74 | 22.43 |
PE Ratio
|
|||
| 1.60 | 1.84 | 1.39 | 1.84 | 1.52 | 1.47 | 1.91 | 1.69 | 1.63 | 1.50 |
PS Ratio
|
|||
| 47.21 | 0.00 | 51.41 | 34.63 | 16.46 | 8.96 | 13.59 | 16.70 | 18.29 | 16.75 |
PB Ratio
|
|||
| 1.88 | 2.06 | 1.63 | 2.02 | 1.66 | 1.60 | 2.11 | 1.93 | 1.88 | 1.73 |
EV/Sales
|
|||
| 21.51 | 19.45 | 47.22 | 20.76 | 16.89 | 13.95 | 22.66 | 20.90 | 25.27 | 18.84 |
EV/FCF
|
|||
| 5,189 | 6,476 | 3,138 | 7,311 | 8,183 | 9,221 | 7,802 | 7,920 | 6,972 | 8,557 |
Op' Cash Flow
|
|||
| (1,063) | (1,177) | (1,278) | (1,484) | (1,766) | (1,522) | (1,670) | (1,691) | (1,685) | (1,649) |
Capex
|
|||
| 4,126 | 5,299 | 1,860 | 5,827 | 6,417 | 7,699 | 6,132 | 6,229 | 5,287 | 6,908 |
FCF
|
|||
| 2,566 | 4,592 | 1,705 | 3,123 | 5,445 | 5,818 | 5,104 | 3,584 | 2,429 | 2,027 |
Working Cap'
|
|||
| 14,282 | 14,263 | 14,104 | 12,654 | 12,169 | 12,002 | 15,547 | 17,459 | 20,270 | 21,700 |
Total Debt
|
|||
| 12,445 | 11,402 | 13,332 | 11,140 | 9,009 | 8,398 | 13,000 | 16,017 | 17,787 | 17,579 |
Net Debt
|
|||
| 1,606 | (776) | 1,449 | 3,171 | 6,038 | 10,959 | 9,266 | 6,835 | 6,333 | 6,721 |
Sh' Equity
|
|||
| 10.65% | 4.16% | 11.03% | 13.48% | 13.91% | 12.43% | 11.05% | 13.14% | 9.87% | 8.69% |
ROA
|
|||
| 26.19% | 39.67% | 31.01% | 37.32% | 35.90% | 29.46% | 23.43% | 23.27% | 18.17% | 19.88% |
ROIC
|
|||
| 219.99% | 473.01% | 1,499.55% | 269.70% | 148.40% | 74.31% | 56.68% | 85.96% | 81.04% | 76.87% |
ROE
|
|||
Lockheed Martin Corporation peers in Aerospace & Defense
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| BA The Boeing Company | $156.4B | 74.2× | Compare |
| HWM Howmet Aerospace Inc. | $91.7B | 49.9× | Compare |
| GD General Dynamics Corporation | $91.2B | 20.3× | Compare |
| NOC Northrop Grumman Corporation | $72.4B | 16.2× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| TDG Transdigm Group Incorporated | $61.3B | 33.9× | Compare |
| RTX RTX Corporation | $253.9B | 32.9× | Compare |
| RKLB Rocket Lab Corporation | $44.8B | 0.0× | Compare |
| LHX L3Harris Technologies Inc | $44.5B | 23.9× | Compare |
LMT metrics, ten years each
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
Lockheed Martin Corporation (LMT) key facts
- Lockheed Martin Corporation (LMT) is an Aerospace & Defense company in the Industrials sector, listed on the New York Stock Exchange.
- Lockheed Martin Corporation’s revenue for fiscal 2025 (year ended December 2025) was $75.0 billion, up 5.64% from fiscal 2024.
- Net income was $5.0 billion, or $21.56 per share (basic), a net margin of 6.69%.
- As of September 25, 2026, LMT traded at $519.56, a market capitalization of $120.7 billion.
- At that price the stock trades at 19.1× trailing-twelve-month earnings and 1.6× sales.
- Lockheed Martin Corporation pays an annual dividend of $12.00 per share, a yield of 2.99%, with a payout ratio of 43.3%.
- Return on equity was 76.9% and debt-to-equity 2.34.
Lockheed Martin Corporation (LMT) Latest News
25 Sep
Lockheed Martin received its first Patriot PAC-3 MSE interceptor housing components from GM Defense, delivered Aug. 28—only 22 days after the August 6 manufacturing agreement. The near-immediate delivery defies the usual months-to-years timeline as the Pentagon pressures faster weapons production amid rising Patriot demand. The U.S. Army’s seven-year PAC-3 MSE production program, worth up to $58.6 billion from fiscal 2026–2032, supports Lockheed’s plan to raise annual interceptor output toward 2,000. GM’s precision automotive capabilities could alleviate bottlenecks, diversify Lockheed’s supplier base, and enable repeat deliveries if quality holds. However, a single early shipment does not prove scalable defense manufacturing; contract value and volumes aren’t disclosed, and GM must repeat the performance at scale while Lockheed undertakes an $8–$9 billion capacity buildout through 2030. The move is strategically meaningful for both, with limited near-term financial impact." Enables potential scale-up of Patriot production and supply-chain diversification, but near-term revenue impact remains uncertain.
U.S. Army awards Lockheed Martin an IDIQ contract worth up to $1.2B to produce Precision Strike Missile (PrSM) Increment 2, covering initial procurement, future orders and continued development. Work will be performed at Lockheed facilities and across the U.S. industrial base. Increment 2 adds a multimode seeker to engage moving land and maritime targets, expanding long-range strike capabilities. The award accompanies expansion of PrSM manufacturing capacity, with production to quadruple and additional Increment 2 flight tests planned for 2027, with initial production to begin under the contract. The company also reported strong Q2 2026 results — sales $20.1B, operating profit $2.5B, net earnings $1.8B, free cash flow $2.9B — and raised full-year guidance, alongside a record backlog of $230B. UBS upgraded LMT to Buy, reflecting missiles/munitions upside and broader defense demand. IDIQ award and capacity expansion meaningfully lift Lockheed’s long-range missiles business and earnings potential.
Lockheed Martin pledged $10 million to support Canada's integrated defence ecosystem linked to HIMARS procurement, expanding its role as a mission partner and on-site manufacturing ally. The company also reported international progress: Mexico expanding its C-130J fleet and Germany advancing F-35A deliveries, events that could help convert its roughly $230 billion backlog into multi-year revenue and cash flow. While these catalysts bolster growth, fixed-price constraints and legacy programs remain concerns. The article emphasizes watching concrete orders: follow-on HIMARS awards, Canada ecosystem awards, any additional Mexican C-130J commitments, and the pace of F-35A deliveries into Germany through 2027 as signals the thesis is unfolding. It cites a $638 fair value and notes investors should monitor milestones, with Simply Wall St flagging one warning sign. In sum, international deals and ecosystem funding extend Lockheed's revenue base beyond hardware into integrated defense solutions. International ecosystem funding and milestone orders point to meaningful, multi-year revenue potential, though execution risks and legacy programs temper near-term gains.
Lockheed Martin (LMT) draws investor attention as shares fall 7.5% in the last month, underperforming the S&P 500 (+0.7%) and the Aerospace-Defense group (−8.2%). Emphasis is on earnings-estimate revisions, a key driver of fair value and near-term moves. Zacks ranks LMT #2 (Buy) due to a notable revision in consensus estimates. Current-quarter EPS is expected at $7.25, up 4.3% YoY, with the 30-day revision at −0.4%. Full-year EPS $30.45 (+31.7%); next year $33.02 (+8.4%). Current-quarter revenue forecast is $20.35B (+9.4%), with $80.82B and $84.82B for this and next fiscal years (+7.7%, +5%). Last quarter reported revenue $20.06B and EPS $7.94, beating estimates by 3.26% and 9.97%. Three of four quarters beat. Value Style Score B indicates stock trades at a discount to peers. Near-term upside possible due to revisions. Near-term upside may materialize from earnings revisions, but no fundamental strategic shift is indicated.
24 Sep
The Department of War (DoW) signed seven-year framework agreements with General Dynamics’ Ordnance and Tactical Systems and Lockheed Martin to triple PAC-3 MSE and quadruple THAAD interceptor capacity by expanding subcomponent manufacturing. The deals provide multi-year demand visibility, supporting Lockheed Martin’s backlog and long-cycle cash generation, while giving General Dynamics a durable path to scale its subcomponents production. Risks include initial ramp costs and potential margin compression for Lockheed, plus reliance on annual appropriations affecting cash flow. For GD, bottlenecks from single-source suppliers could slow ramp speed and margins could compress if broader defense budgets stall. Overall, the framework is constructive for both firms; success depends on efficient ramp-up, supply-chain management, and maintaining margins. GD gains backlog visibility; LMT solidifies missile-defense prime position, with margins and leverage to watch during scale-up. Creates durable demand visibility and strengthens Lockheed's missile-defense prime position, but raises ramp and margin risks.
Lockheed Martin is positioned to benefit from rising defense spending as the U.S. and allies buy more F-35s. Saudi Arabia cleared a deal for 48 F-35s worth $24.3 billion, though Congress must ratify. Germany has taken delivery of its first F-35s and ordered 35; more may follow as a Europe-made alternative fades. The Pentagon plans 85 F-35s in fiscal 2027, up from 47 in 2026. DoD contracts to raise PAC-3 interceptor production could push output toward $58.6 billion in value; a seven-year THAAD program has a $35 billion ceiling and will quadruple output. A Pentagon deal to expand AIM-260 JATM missiles should boost sales. Despite fears of Democratic defense cuts, such cuts appear unlikely; Lockheed trades at a forward P/E of 17.1x, below the S&P 500 and ITA, with a consensus Moderate Buy. Rising multi-year demand for F-35s and interceptors, plus production expansions, could meaningfully boost revenue and investor sentiment.
Lockheed Martin (LMT) and L3Harris Technologies (LHX) show different growth profiles. LMT, larger and more diversified, is exposed to fighter aircraft, missiles, space systems and missile defense, while LHX focuses on communications, electronic warfare, sensing and space/missile tech. Demand for LMT is translating into longer-duration awards and a record backlog of about $230 billion as of June 28, 2026, supported by a $65 billion second-quarter order flow and a 3.2 book-to-bill. Notable wins include THAAD, GMLRS, HIMARS, radar and space programs; second-quarter missiles and fire control sales rose 19%, with segment profit up 24%. LMT is expanding production capacity in Alabama and Florida. LHX backs a smaller backlog of $42 billion; Q2 orders of $7.3 billion, 1.2x book-to-bill, and a growing space/missile pipeline totaling roughly $9 billion. Zacks ranks LMT #2 Buy and LHX #3 Hold. Record backlog and expanding production capacity for key programs boost revenue visibility and near-term earnings potential for Lockheed Martin.
UBS upgraded Lockheed Martin (LMT) to Buy from Neutral on Sept. 8, raising the target to $674 as it argues a missile-driven earnings shift is underpricing the stock. Within days, three catalysts reinforced the view: a framework agreement to accelerate AIM-260 JATM production; State Department approval of a $24.3 billion F-35 sale to Saudi Arabia; and the Army awarding up to $1.2 billion for the Precision Strike Missile. In Q2, Lockheed posted $20.06 billion revenue (up 11% YoY) and adjusted EPS of $7.94, beating consensus, with backlog a record $230 billion including a $35B THAAD contract. Management stressed scale-up of PAC-3 and THAAD and introduced Sanctum drone-counter system, prompting a rapid scale-up. The bear case remains: supplier capacity and fixed-price charges. Valuation shows LMT around $798 by 2030, driven by missiles ramp and F-35 sustainment, with downside if margins don’t recover. Missile ramp and margin recovery drive potential upside, but execution risk and fixed-price contracts provide significant downside potential.
Debate pits Boeing Co. and Lockheed Martin as essential U.S. aerospace plays for 2026. Boeing blends commercial jets with defense, reporting FY2025 revenue about $89.5B, net income ~$2.2B, 2.5% net margin, and a heavy balance sheet (debt/equity 10x; negative free cash flow). FAA scrutiny, production delays, and Spirit AeroSystems integration add risk. Lockheed Martin is defense-focused, with FY2025 revenue about $75.1B, ~5% growth, ~7% net margin, debt/equity 3.2x, and ~$6.9B in free cash flow; Jumps in U.S. DoD spending underpin a stable outlook, notably F-35 sales (about 27% of revenue). Valuation favors Lockheed, which shows cheaper earnings and sales multiples; Boeing offers longer-term upside tied to commercial aviation and defense programs despite near-term headwinds. Defense-focused revenue and long-term DoD funding support steady cash flow, but litigation and DoD budget risk temper upside.
23 Sep
Lockheed Martin’s Missiles and Fire Control (MFC) posted strong Q2 2026 results, with sales up 19% year over year to $4.1 billion and segment operating profit rising 24% to $594 million, driven by higher volumes on PAC-3, THAAD and PrSM programs. THAAD backlog expansion, supported by an undefinitized contract action, lifted total backlog to $230.4 billion as of June 28, 2026, adding $36.8 billion in six months and boosting current production visibility. LMT raised its full-year 2026 MFC outlook to $16.5–$16.9 billion in sales and $2.3–$2.35 billion in operating profit. Growth across Aeronautics (higher F-35 volumes), Space (Next Generation Interceptor, Fleet Ballistic Missile) and Rotary & Mission Systems (Sikorsky ramp-up, radar awards) underpins the broader growth trajectory, with peers RTX and Northrop Grumman noted for missile-defense exposure and valuation commentary. Backlog expansion, higher MFC demand and raised guidance point to a meaningful uplift in revenue and profit trajectory.
Sentinel Advanced Military Solutions, a Quebec-based defence integrator and CMP subsidiary, launched the Sentinel Defence Consortium at CANSEC 2026 to speed deployable defence tech across Canada. Anchored by Sentinel’s StarForge platform, the network links regional partners from Atlantic Canada to Alberta to detect threats, coordinate responses, and manufacture components on site—including 3D-printed parts—at edge locations such as Arctic outposts or forward operating bases. CMP provides manufacturing scale to convert research into field-ready systems, enabling rapid production where supply chains don't reach. The ecosystem emphasizes sovereign, scalable capability for Canada and NATO allies, backed by a $10 million Industrial and Technological Benefits contribution from Lockheed Martin tied to Canada’s HIMARS procurement. Lockheed supplies the primary C2 system (VCSi), sensor fusion, and SME support; the University of Alberta anchors the R&D and testing. Lockheed Martin’s ITB funding signals stronger Canadian presence and potential future opportunities, with moderate impact on LMT’s prospects in Canada.
Pentagon awards on Sept. 14 totaled roughly $1.9 billion for Boeing and Lockheed Martin. Boeing won a $562 million Navy contract to move the MQ-25A Stingray into low-rate production, a milestone for a program long delayed. Lockheed Martin secured more than $1.3 billion across three awards, led by a $1.21 billion contract for the Precision Strike Missile Increment 2. Yet the market gave little reaction to either win. Boeing trades at about 85 times trailing earnings with net margins around 2.4% and carries a heavy debt load, suggesting the stock reflects a robust turnaround rather than just new contracts. Lockheed, by contrast, trades around 17 times forward earnings, yields about 2.6% dividend, and boasts a higher margin profile, but is valued as a stock that needs margin expansion and stronger free cash flow to re-rate. Analysts see upside for both, but confidence hinges on execution and defense budgets. Backlog growth improves visibility, but profitability and cash flow remain a key uncertainty.
Fuerza Aérea Mexicana has ordered a second Lockheed Martin C-130J-30 Super Hercules, following January 2026 first aircraft, making Mexico the first Latin American nation in Lockheed’s Super Hercules fleet. The stretched C-130J-30 adds 15 feet of cargo space, with greater power, range, fuel efficiency and payload for broader tactical airlift, disaster relief and humanitarian missions. The second aircraft will double Mexico’s rapid-response capability in Latin America and reinforce its regional security role alongside U.S. and allied forces. Lockheed Martin officials tout the platform’s multi-mission versatility and interoperable global support network. The move comes as humanitarian crises and natural disasters in the region underscore the Hercules’ value in response operations, including post-disaster relief after Venezuela’s earthquakes, highlighting sustained momentum for modern air mobility in the region. New order signals sustained regional demand for the C-130J-30, modestly supporting Lockheed's revenue and backlog while not representing a game-changing shift.
StockStory flags Carvana as the sole buy, while Movado and Lockheed Martin are rated to be sold. Movado shows five-year sales stagnation and a free cash flow margin around 6.5%, implying limited growth and capital-allocation flexibility. Lockheed Martin is criticized for a large revenue base with only 2.9% five-year growth, flat EPS over the past two years, and shrinking returns on capital, with a forward EV/EBITDA around the mid-teens. Carvana is highlighted for rising Retail Units Sold (about 37.7% annually), growing platform usage, and EPS up roughly 43.6% annually, with a forward EV/EBITDA around 15.7x. Overall, LMT is portrayed as underperforming and MOV unattractive, while CVNA is presented as the investable opportunity on the list. Notes flat EPS growth and shrinking returns on capital, signaling a moderate sentiment impact without implying fundamental changes.
Lockheed Martin signed a framework agreement with the U.S. Department of Defense on September 17 to accelerate production of the AIM-260 Joint Advanced Tactical Missile (JATM) to counter China's air threat. While it signals long-term demand, it stops short of a multiyear contract because Congress must approve funding and define contract values. Lockheed is funding capacity expansions ahead of any award, and no production target or price is disclosed. JATM is expected to offer extended range versus the AIM-120 AMRAAM and will be compatible with F-22 and F-35. Australia has committed about A$736 million as the program’s first international customer. Lockheed also recently secured an IDIQ ceiling for the Army’s PrSM Increment 2. Analysts warn of execution risk if demand does not materialize, while hedge funds trimmed positions and short interest remains modest. The outcome hinges on Congressional funding. A funded multiyear JATM contract could meaningfully boost long-term revenue, but funding and contract specifics remain uncertain.
22 Sep
Lockheed Martin won an Army contract worth up to $1.2 billion to develop and produce the Precision Strike Missile (PrSM) Increment 2 under an indefinite-delivery, indefinite-quantity agreement. The deal covers initial purchases, future orders, and ongoing development, and backs work across Lockheed’s U.S. manufacturing network. The program has advanced with recent flight tests—second test in August following one in March—demonstrating the missile’s ability to engage a moving target at sea. Increment 2 adds a multimode seeker for moving land and sea targets. Additional flight testing is planned in 2027. The Army expects larger PrSM purchases, prompting Lockheed to expand capacity and pursue a plan to quadruple output while continuing development of later variants. Significant expansion in production capacity and a major contract for PrSM Increment 2 could meaningfully affect revenue potential and competitive positioning.
Germany's first F-35A Lightning II is handed to the German government at Lockheed Martin's facility, underscoring an expanding F-35 franchise chosen by 20 nations. Germany’s 35-aircraft program could create a long-term revenue pipeline for Lockheed across training, production, and sustainment. The initial eight aircraft will head to Ebbing Air National Guard Base in Arkansas for pilot training, with the first German jets due in late 2027. Lockheed Aeronautics president OJ Sanchez emphasizes the F-35 as a strategic capability for allied interoperability and deterrence. The piece also notes a broader push into international manufacturing: Lockheed’s Javelin JV with Raytheon signed an MOU with Tata Advanced Systems Limited to explore co-production in India, expanding the potential market and supply stability. Risks include schedule delays to 2029 for full capability, possible Germany defense-budget shifts, and political-economic headwinds that could affect backlog and industrial plans. Hedge funds remain engaged; State Street is the largest holder. Expands European program backlog and long-term revenue through training, production, and sustainment with Germany and partners, a major strategic driver.
Lockheed Martin secured an indefinite-delivery, indefinite-quantity contract worth up to $1.2 billion for Increment 2 of its Precision Strike Missile, moving the system into production. The stock trades at $535.40 with a 90-day gain of 6.3% and a 1-year total return of 14.33%, though the 30-day return is down 5%. Recent wins in missiles, ongoing F-35 milestones in Europe, and new partnerships in quantum computing bolster growth arguments against valuation concerns. Simply Wall St pins a fair value of $673.88 and frames LMT as largely undervalued under a 20.5% undervalued narrative, with Orbit as a long-term growth theme and Aero+Defense as the cash engine. Risks include potential Orbit cost overruns or slower orders from big defense customers. Investors are advised to weigh the contract, dividend income, and valuation against risk and review five rewards and one warning sign. A $1.2B PrSM increment contract and related growth narrative could materially affect cash flow and investor sentiment, though risks and valuation sensitivity temper the impact.
Lockheed Martin (LMT) fell 2.44% to $522.34 in the latest session as the Dow declined 0.36% and the Nasdaq rose 0.45%. The stock had already slipped 5.09% this week, underperforming the Aerospace sector (-8.1%) and the S&P 500 (+1.27%). Investors await the upcoming earnings release, with consensus calls for $7.25 per share (up 4.3% YoY) and revenue of about $20.35 billion (up ~9.4%). Full-year Zacks estimates project $30.45 per share and $80.82 billion in revenue (YoY +31.7% and +7.7%). The firm notes positive estimate revisions and assigns LMT a Zacks Rank of #2 Buy. Forward P/E is 17.59 vs. industry 23.69, and PEG is 1.16, with Aerospace-Defense industry ranked in the top 42%. Near-term earnings expectations and positive revisions could influence sentiment, though core fundamentals and long-term trajectory remain balanced by other factors.
Ducommun (DCO) has outsized the aerospace group in 2024, up about 76.7% year-to-date while the sector has fallen roughly 7.9%. Lockheed Martin (LMT) has also outperformed, gaining about 10.7% YTD. Within Zacks' framework, DCO carries a #1 Strong Buy rank, with the full-year earnings consensus moving up about 4.7% in the past quarter, signaling improving sentiment. LMT holds a #2 Buy rank, with its current-year EPS consensus rising 1.9% over the last three months. Ducommun sits in the Aerospace - Defense Equipment industry (a group of 36), which has on average seen declines this year; Lockheed Martin sits in the Aerospace - Defense industry (39 stocks) that has also fallen about 8.9% YTD. The piece urges investors to continue tracking both names as they push to sustain solid performance relative to peers. Moderate sentiment improvement and a strong year-to-date gain support LMT, but no major strategic moves or new programs are disclosed.
21 Sep
Lockheed Martin unveiled the AIM-260 Joint Advanced Tactical Missile (JATM), a classified next-generation air-to-air weapon designed to extend range and effectiveness against advanced threats such as China's J-20. The missile will be integrated with the F-22 and F-35, while Lockheed signed a framework with the U.S. Department of Defense to accelerate production and prepare for a multiyear procurement program. Australia committed roughly $521 million to JATM, though unit price and quantities are undisclosed. The move comes as the U.S. and allies replenish inventories and Lockheed expands munitions capacity with an $8-9 billion investment across more than 20 U.S. sites, including PAC-3 MSE, THAAD, and Precision Strike Missile capacity. In 2025, Missiles and Fire Control sales rose 14% to $14.45 billion; backlog reached $46.65 billion. Near-term earnings impact remains uncertain due to pricing and timing of full-rate delivery. AIM-260 and a multiyear procurement framework could materially boost sales, backlog, and production scale, shaping Lockheed's long-term profitability.
Lockheed Martin won an indefinite-delivery, indefinite-quantity contract worth up to $1.2 billion to produce Increment 2 of the Precision Strike Missile (PrSM) for the U.S. Army. Increment 2 adds a multimode seeker enabling engagement of moving land and maritime targets, expanding long-range strike options. The award follows two PrSM flight tests, including a second test that demonstrated the ability to engage a moving maritime target; tests included launching from a HIMARS and deploying protective covers. Work will be performed at Lockheed facilities and across the U.S. industrial base. Production will ramp up alongside ongoing flight testing and system maturation with additional tests planned for 2027. Lockheed aims to quadruple PrSM production; Increment 2 aligns with broader Army investments in long-range fires. Significant revenue potential and strategic expansion in PrSM production and moving-target capability, enhancing Lockheed's defense portfolio and scale.
Lockheed Martin pursued a high-profile secret project that reportedly reshaped American defense. The piece depicts a startup-like mindset inside the defense contractor—rapid iteration, bold risk-taking, and cross-domain collaboration intended to deliver breakthrough capabilities faster than traditional programs. It outlines potential effects on military readiness, industrial competitiveness, and procurement, alongside the cultural and strategic shifts needed to sustain such innovation. Despite secrecy, officials suggest long-term influence across technology, suppliers, and partnerships. The narrative casts the company as using agility to outpace rivals in a rapidly evolving security landscape, with potential implications for investors and policy. A transformative secret program can reshape defense capabilities and investor expectations, aligning with a higher growth trajectory for Lockheed Martin.
Lockheed Martin is strengthening its position in strategic missiles as the U.S. Navy modernizes ballistic capabilities. In Space, LMT is supporting the Trident II (D5) Life Extension 2 program, with a $76.6 million contract modification for advanced design and development. The work through September 2030 aims to extend the Trident II D5's service life and preserve deterrent capabilities. The program underpins ongoing demand for ballistic missile life-extension and highlights sustained investment in strategic systems. Lockheed's established role on Trident II provides deep expertise and positions the company to benefit from continued modernization. The development activity offers visibility into future opportunities in this market, complementing other defense firms also benefiting from missile and strategic defense demand. Secures multi-year backlog and steady demand for Lockheed Martin's missile systems, supporting long-term revenue and market position.
Lockheed Martin is proceeding with its Vectis stealth drone after the Air Force awarded CCA contracts to rivals Anduril Industries and General Atomics, effectively sidelining Lockheed in the competition for the drones themselves. The decision splits CCA work: Anduril and GA will build the airframe (FQ-42 and FQ-44) while the autonomy software will be sold separately to multiple vendors, with Lockheed still on the software shortlist. Vectis is described as a Group 5, MQ-9-sized fighter-supported/independent drone designed for surveillance, counter-air and strike missions, featuring stealth and software-agnostic compatibility to encourage mass purchases. Lockheed is funding Vectis development itself, betting future Air Force demand could widen the field later. Financially, the company remains strong: about $6.3B in net profit, $8.7B in free cash flow, a roughly $123B market cap and a 2.6% dividend. Lockheed's Vectis on-spec investment could reshape its long-term positioning and future procurement opportunities despite not securing current CCA wins.
GM Defense delivered the first housing-component batch for Lockheed Martin's PAC-3 MSE system on Aug. 28, following a June collaboration and an Aug. 6 contract; value was not disclosed. The partners aim to apply commercial manufacturing practices to munitions programs and expand capabilities for other defense systems for the U.S. and its allies. GM leveraged casting, machining, and precision fabrication to meet defense specs and scale production with consistent quality. The next batch will test monthly output, quality, and rework rates as volumes ramp. Lockheed has pursued accelerated PAC-3 production through recent Defense Department awards and deals with L3Harris for propulsion, plus efforts to broaden JATM capacity, amid broader concerns about U.S. weapons shortages. It signals a meaningful boost to Lockheed's PAC-3 MSE production capacity and supply-chain resilience through automotive-scale manufacturing.
Lockheed Martin's payout ratio jumped to 225.44% in June 2025 due to one-time earnings adjustments and is expected to normalize to 43.36% by June 2026, while the company raises full-year 2026 guidance. CFO Evan Scott said $796 million was returned to shareholders through dividends in Q2 2026 as free cash flow swung from negative to $2.9 billion. The quarterly dividend rose to $3.45; the yield sits near 2.69%. Backlog reached $230 billion, with a 3.2-to-1 book-to-bill, and capital and R&D investments supported next-gen munitions and automated manufacturing. Management projects continued dividend growth alongside higher guidance and backs a $811 target price by December 2030, implying roughly 52% total return and about 10% annualized from today. Raised guidance and stronger free cash flow alongside a growing backlog and a maintained dividend create meaningful upside without a strategic overhaul.
GM Defense and Lockheed Martin signed an Aug. 6, 2026 agreement to supply mission-critical components for Lockheed's Patriot PAC-3 MSE interceptor; first shipment arrived Aug. 28, 2026. GM Defense won't reveal contract value or volumes. By leveraging GM's casting and machining capabilities, the partners aim to strengthen the U.S. defense industrial base and speed production. GM CEO Mary Barra says the defense unit is a significant growth driver; GM expects about $700 million in defense revenue in 2026 with a backlog and potential double-digit margins on future programs. The piece notes potential further collaboration and a possible $1 billion contract to manufacture 10,000 Infantry Squad Vehicles for the U.S. military, highlighting broader defense ecosystem opportunities for GM and its partners, including Lockheed. Adds modest, non-core supplier exposure that could benefit LMT gradually without immediate transformative impact.
Lockheed Martin is under a U.S. House inquiry over the diversion of F-35 jet components, reportedly shipped from Australia to Hong Kong rather than the United States. The probe raises export-control and supply-chain-security concerns and could impose regulatory or reputational costs on the defense contractor. Investigators are examining shipments and controls around sensitive parts, with potential implications for future licensing, compliance practices, and international operations—though specifics and outcomes remain unclear. Regulatory scrutiny from a House probe could modestly affect compliance costs and export-control risk, influencing investor sentiment and near-term operations.
18 Sep
Lockheed Martin initiates first F-35 sales push to Saudi Arabia and rolls out F-35A for Germany. F-35 expansions into Saudi Arabia and Germany open major new international revenue streams for core defense programs.